|
1.
|
|
10 p, 556.3 KB |
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset
/
Meisl, Christina J. (Department of Urology. Charité - Universitätsmedizin Berlin. Corporate Member of Freie Universität Berlin. Humbold-Universität zu Berlin. and Berlin Institute of Health) ;
Karakiewicz, Pierre I. (University of Montreal. Department of Surgery) ;
Einarsson, Roland (IDL Biotech) ;
Koch, Stefan (Brandenburg Medical School Theodor Fontane) ;
Hallmann, Steffen (HELIOS Hospital Bad Saarow. Department of Urology) ;
Weiß, Sarah (HELIOS Hospital Bad Saarow. Department of Urology) ;
Hemdan, Tammer (Uppsala University. Department of Surgical Sciences) ;
Malmström, Per-Uno (Uppsala University. Department of Surgical Sciences) ;
Styrke, Johan (Umeå University. Department of Surgical and Perioperative Sciences. Urology and Andrology) ;
Sherif, Amir (Umeå University. Department of Surgical and Perioperative Sciences. Urology and Andrology) ;
Hasan, Mudhar N. (Danderyd Hospital. Department of Urology) ;
Pichler, Renate (Medical University Innsbruck. Department of Urology) ;
Tulchiner, Gennadi (Medical University Innsbruck. Department of Urology) ;
Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Hennenlotter, Jörg (University Hospital Tübingen. Department of Urology) ;
Stenzl, Arnulf (University Hospital Tübingen. Department of Urology) ;
Ritter, René (Diakonie-Klinikum Stuttgart. Department of Urology) ;
Niegisch, Günter (Heinrich Heine University Düsseldorf. Department of Urology. Faculty of Medicine) ;
Grunewald, Camilla M. (Heinrich Heine University Düsseldorf. Department of Urology. Faculty of Medicine) ;
Schlomm, Thorsten (Department of Urology. Charité - Universitätsmedizin Berlin. Corporate Member of Freie Universität Berlin. Humbold-Universität zu Berlin. and Berlin Institute of Health) ;
Friedersdorff, Frank (Evangelisches Krankenhaus Königin Elisabeth Herzberge. Department of Urology) ;
Barski, Dimitri (Rheinland Klinikum Neuss. Department of Urology) ;
Otto, Thomas (University of Duisburg-Essen. Medical Faculty) ;
Gössl, Andreas (HELIOS Hospital Krefeld. Department of Urology) ;
Arndt, Christian (HELIOS Hospital Krefeld. Department of Urology) ;
Esuvaranathan, Kesavan (National University Hospital. Department of Urology) ;
Kesavan, Nisha R. (National University Hospital. Department of Urology) ;
Zhijiang, Zang (National University Hospital. Department of Urology) ;
Kramer, Mario W. (University Hospital Schleswig-Holstein Campus Lübeck. Department of Urology) ;
Hennig, Martin J.P. (University Hospital Schleswig-Holstein Campus Lübeck. Department of Urology) ;
Ecke, Thorsten H. (HELIOS Hospital Bad Saarow. Department of Urology) ;
Universitat Autònoma de Barcelona
Objectives: To evaluate the clinical utility of the urinary bladder cancer antigen test UBC Rapid for the diagnosis of bladder cancer (BC) and to develop and validate nomograms to identify patients at high risk of primary BC. [...]
2022 -  10.1111/bju.15677
BJU International, Vol. 130 Núm. 6 (december 2022) , p. 754-763
|
|
|
2.
|
|
9 p, 891.1 KB |
Small renal masses in Latin-American population : Characteristics and prognostic factors for survival, recurrence and metastasis - A multi-institutional study from LARCG database
/
Mourão, T.C. (A.C. Camargo Cancer Center) ;
Abreu, Diego (Pasteur Hospital) ;
Carvalhal, Gustavo Franco (São Lucas Hospital - PUCRS) ;
Gueglio, Guillermo M. (Italian Hospital) ;
da Costa, Walter Henriques (A.C. Camargo Cancer Center) ;
Calsavara, Vinicius Fernando (A.C.Camargo Cancer Center) ;
Meza-Montoya, Luis (Instituto Nacional de Enfermedades Neoplásicas) ;
Bengió, Rúben Guillermo (Urological Center Profesor Bengió) ;
Scorticati, Carlos H. (Clinics Hospital José de San Martín) ;
Castillejos-Molina, Ricardo Alonso (Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCNSZ)) ;
Rodriguez-Covarrubias, Francisco (Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCNSZ)) ;
Autran Gómez, Ana María (Hospital Universitario Fundación Jiménez Díaz) ;
Campos-Salcedo, José Gadú (Military Hospital) ;
Nolazco, Alejandro (Hospital Británico de Buenos Aires) ;
Ameri, Carlos Alberto (Hospital Alemán (Buenos Aires)) ;
Zampolli, Hamilton De Campos (Instituto Arnaldo Vieira de Carvalho) ;
Langenhin, Raúl (Corporación Médica de Paysandú (COMEPA)) ;
Muguruza, Diego (Corporación Médica de Paysandú (COMEPA)) ;
Tobias-Machado, Marcos (ABC Medical School) ;
Mingote, Pablo (Policlínico Neuquén) ;
Clavijo, Jorge (Clinics Hospital) ;
Nogueira, Lucas Mendes (Federal University of Minas Gerais) ;
Clark, Omar (Military Hospital) ;
Rovegno, Agustín Roberto (Centro de Educación Médica e Investigaciones Clínicas (CEMIC)) ;
Secín, Fernando Pablo (San Lázaro Foundation and FUNDES) ;
Decia, Ricardo (Hospital Pasteur Montevideo) ;
Cardoso Guimarães, Gustavo (Surgical Oncology Coordinator at Beneficencia Portuguesa Hospital) ;
Glina, Sidney (Ipiranga Hospital) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Zequi, Stênio de Cássio (AC Camargo Cancer Center) ;
Universitat Autònoma de Barcelona
To evaluate demographic, clinical and pathological characteristics of small renal masses (SRM) (≤ 4 cm) in a Latin-American population provided by LARCG (Latin-American Renal Cancer Group) and analyze predictors of survival, recurrence and metastasis. [...]
2020 - 10.1186/s12894-020-00649-8
BMC Urology, Vol. 20 Núm. 1 (february 2020) , p. 85
|
|
|
3.
|
|
19 p, 1.1 MB |
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer : Systematic Review on the Performance of Risk Stratification Models
/
Guerrero-Ramos, F. (Hospital Universitario 12 de Octubre (Madrid). Servicio de Urología) ;
Subiela, J.D. (Hospital Ramón y Cajal. Servicio de Urología. Instituto Ramón y Cajal de Investigación Sanitaria. Universidad De Alcalá) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Aumatell, Julia (Fundació Puigvert. Servicio de Urología) ;
Manfredi, Celeste (Unit Of Urology. Department Of Woman. Child And General And Specialized Surgery. University Of Campania 'Luigi Vanvitelli') ;
Bozzini, Giorgia (Department Of Urology. Asst Lariana Ospedale Sant'Anna) ;
Romero-Otero, Javier (Department Of Urology. Hospital Universitario Hm Sanchinarro) ;
Couñago, Felipe (Hospital La Milagrosa)
BACKGROUND: Several classifications have been reported to stratify non-muscle-invasive bladder cancer (NMIBC) in risk groups according to the probability of recurrence and progression. OBJECTIVE: To systematically review the current evidence regarding risk stratification of NMIBC. [...]
2022 - 10.3233/BLC-220055
Bladder Cancer, Vol. 8 Núm. 4 (2022) , p. 339-357
|
|
|
4.
|
|
128 p, 6.1 MB |
Recommendations for living donor kidney transplantation Recomendaciones para el trasplante renal de donante vivo
/
Frutos, Migeul Ángel (Hospital Regional Universitario de Málaga) ;
Crespo, Marta (Hospital del Mar (Barcelona, Catalunya)) ;
Valentín, María de la Oliva (Organización Nacional de Trasplantes (Espanya)) ;
Alonso-Melgar, Ángel (Hospital Universitario La Paz (Madrid)) ;
Alonso, Juana (Hospital Regional Universitario de Málaga) ;
Fernández, Constantino (Hospital Universitario A Coruña. Servicio de Nefrología) ;
García-Erauzkin, Gorka (Hospital Universitario de Cruces. Servicio de Nefrología) ;
González, Esther (Hospital 12 de Octubre (Madrid)) ;
González-Rinne, Ana M. (Hospital Universitario de Canarias. Servicio de Nefrología) ;
Guirado, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Gutiérrez-Dalmau, Alex (Hospital Universitario Miguel Servet (Saragossa)) ;
Huguet, Jorgue (Fundació Puigvert. Equip quirúrgic de Trasplantament Renal) ;
López del Moral, José Luis (Magistrado del Tribunal Superior de Justicia de Cantabria) ;
Musquera, Mireia (Hospital Clínic i Provincial de Barcelona. Servei d'Urologia) ;
Paredes, David (Hospital Clínic i Provincial de Barcelona. Donació i Coordinació de Trasplantament) ;
Redondo, Dolores (Hospital del Mar (Barcelona, Catalunya)) ;
Revuelta, Ignacio (Hospital Clínic i Provincial de Barcelona. Servei de Nefrologia i Trasplantament Renal) ;
Van-der Hofstadt, Carlos J. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Alcaraz, Antonio (Hospital Clínic i Provincial de Barcelona. Servei d'Urologia) ;
Alonso-Hernández, Ángel (Hospital Universitario A Coruña. Servicio de Nefrología) ;
Alonso, Manuel (Coordinación de Trasplantes de Andalucía) ;
Bernabeu, Purificación (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Bernal Blanco, Gabriel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Breda, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Cabello, Mercedes (Hospital Regional Universitario de Málaga) ;
Caro-Oleas, José Luis (Hospital Clínic i Provincial de Barcelona. Servei d'Immunologia) ;
Cid, Joan (Hospital Clínic i Provincial de Barcelona. Unitat d'Afèresi i Teràpia Cel·lular. Servei d'Hemoteràpia i Hemostàsia) ;
Diekmann, Fritz (Hospital Clínic i Provincial de Barcelona. Servei de Nefrologia i Trasplantament Renal) ;
Espinosa, Laura (Hospital Universitario La Paz (Madrid)) ;
Facundo, Carme (Institut d'Investigació Biomèdica Sant Pau) ;
García, Marta (Organización Nacional de Trasplantes (Espanya)) ;
Gil-Vernet, Salvador (Hospital Universitari de Bellvitge. Servei de Nefrologia) ;
Lozano, Miquel (Hospital Clínic i Provincial de Barcelona. Servei d'Hemoteràpia i Hemostàsia.) ;
Mahillo, Beatriz (Organización Nacional de Trasplantes (Espanya)) ;
Martínez, María José (Hospital Universitario La Paz (Madrid)) ;
Miranda, Blanca (Fundación Renal Iñigo Álvarez de Toledo) ;
Oppenheimer, Federico (Hospital Clínic i Provincial de Barcelona. Servei de Nefrologia i Trasplantament Renal) ;
Palou, Eduard (Hospital Clínic i Provincial de Barcelona. Servei d'Immunologia) ;
Pérez-Saez, María José (Hospital del Mar (Barcelona, Catalunya)) ;
Peri, Lluis (Hospital Clínic i Provincial de Barcelona. Servei d'Urologia) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Santiago, Carlos (Hospital General de Alicante. Servicio de Nefrología) ;
Tabernero, Guadalupe (Hospital Universitario de Salamanca. Servicio de Nefrología) ;
Hernández, Domingo (Hospital Regional Universitario de Málaga) ;
Domínguez-Gil, Beatriz (Organización Nacional de Trasplantes (Espanya)) ;
Pascual, Julio (Hospital del Mar (Barcelona, Catalunya))
This Guide for Living Donor Kidney Transplantation (LDKT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). [...]
2022 - 10.1016/j.nefroe.2022.07.001
Nefrología (Badalona. English), Vol. 42 (diciembre 2022) , p. 5-132
|
|
|
5.
|
|
10 p, 248.3 KB |
Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors : Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium)
/
Di Maida, Fabrizio (Unit of Oncologic Minimally-Invasive Urology and Andrology. Department of Experimental and Clinical Medicine. Careggi Hospital) ;
Campi, Riccardo (Unit of Urological Robotic Surgery and Renal Transplantation. Department of Experimental and Clinical Medicine. University of Florence. Careggi Hospital) ;
Lane, Brian R. (Department of Urology. Spectrum Health Medical Group) ;
De Cobelli, Ottavio (Department of Urology. European Institute of Oncology (IEO). University of Milan) ;
Sanguedolce, Francesco (Fundació Puigvert. Unitat d'Urooncologia) ;
Hatzichristodoulou, Georgios (Department of Urology. Martha-Maria Hospital Nuremberg) ;
Antonelli, Alessandro (Department of Urology. University of Verona. Azienda Ospedaliera Universitaria Integrata Verona) ;
Grosso, Antonio Andrea (Unit of Oncologic Minimally-Invasive Urology and Andrology. Department of Experimental and Clinical Medicine. Careggi Hospital) ;
Noyes, Sabrina (Department of Urology. Spectrum Health Medical Group) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Keeley, Frank X. (Bristol Urological Institute. Southmead Hospital) ;
Langenhuijsen, Johan (Radboud University Medical Centre. Department of Urology) ;
Musi, Gennaro (Department of Urology. European Institute of Oncology (IEO). University of Milan) ;
Klatte, Tobias (Department of Urology. Medical University of Vienna) ;
Roscigno, Marco (Department of Urology. ASST Papa Giovanni XXIII) ;
Akdogan, Bulent (Department of Urology. School of Medicine. Hacettepe University) ;
Furlan, Maria (Department of Urology. University of Brescia) ;
Simeone, Claudio (Department of Urology. University of Brescia) ;
Karakoyunlu, Nihat (Department of Urology. Diskapi Yildirim Beyazit Training and Research Hospital) ;
Marszalek, Martin (Department of Urology. Graz Medical University) ;
Capitanio, Umberto (Unit of Urology. Division of Experimental Oncology. Urological Research Institute (URI). IRCCS Ospedale San Raffaele) ;
Volpe, Alessandro (Department of Urology. Maggiore della Carità Hospital. University of Eastern Piedmont) ;
Brookman-May, Sabine (Janssen Pharma Research and Development) ;
Gschwend, Jurgen E. (Department of Urology. Rechts der Isar University Hospital. Technical University of Munich) ;
Smaldone, Marc C. (Division of Urologic Oncology. Fox Chase Cancer Center) ;
Uzzo, Roberto G. (Division of Urologic Oncology. Fox Chase Cancer Center) ;
Kutikov, Alexander (Division of Urologic Oncology. Fox Chase Cancer Center) ;
Minervini, Andrea (Unit of Oncologic Minimally-Invasive Urology and Andrology. Department of Experimental and Clinical Medicine. Careggi Hospital)
Background: To explore predictors of positive surgical margins (PSM) after robotic partial nephrectomy (PN) in a large multicenter international observational project, harnessing the Surface-Intermediate-Base (SIB) margin score to report the resection technique after PN in a standardized way. [...]
2022 - 10.3390/jcm11071765
Journal of clinical medicine, Vol. 11 Núm. 7 (April 2022) , p. 1765
|
|
|
6.
|
|
15 p, 794.8 KB |
Prognostic factors in de novo metastatic renal cell carcinoma : A report from the latin american renal cancer group
/
Abreu, Diego (Hospital Pasteur. Servicio de Urologia (Montevideo, Uruguai)) ;
Carvalhal, Gustavo (Hospital São Lucas da PUCRS (Port Alegre, Brasil)) ;
Gueglio, Guillermo (Hospital Italiano de Buenos Aires (Argentina)) ;
Tobía González, Ignacio Pablo (Hospital Italiano de Buenos Aires (Argentina)) ;
Garcia, Patricio (Hospital Italiano de Buenos Aires (Argentina)) ;
Zuñiga, Alvaro (Pontificia Universidad Católica de Chile) ;
Meza, Luis (Instituto Nacional de Enfermedades Neoplásicas (Llima,Perú)) ;
Bengió, Rúben Guillermo (Centro Urológico Profesor Bengió (Còrdova, Argentina)) ;
Scorticati, Carlos H. (Hospital de Clínicas José de San Martín (Bons Aires, Argentina)) ;
Castillejos, Ricardo (Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (Mèxic)) ;
Rodriguez, Francisco (Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (Mèxic)) ;
Autran Gómez, Ana María (Fundación Jiménez Diaz (Madrid)) ;
González Enguita, María del Carmen (Fundación Jiménez Diaz (Madrid)) ;
Gadú Campos-Salcedo, Jose (Hospital Militar (Mèxic))) ;
Nolazco, Alejandro (Hospital Británico (Argentina)) ;
Ameri, Carlos Alberto (Hospital Alemán (Argentina)) ;
Zampolli, Hamilton Campos (Instituto Arnaldo Vieira de Carvalho (Brasil)) ;
Langenhin, Raúl (Coperativa Médica de Paysandú (Uruguai)) ;
Muguruza, Diego (Coperativa Médica de Paysandú (Uruguai)) ;
Tobias-Machado, Marcos (Centro Universitário Faculdade de Medicina do ABC (Brasil)) ;
Mingote, Pablo (Policlinico Neuquén) ;
Yandian, Juan (Hospital de Clínicas Dr. Manuel Quintela (Montevideo, Uruguai)) ;
Clavijo, Jorge (Hospital de Clínicas Dr. Manuel Quintela (Montevideo, Uruguai)) ;
Nogueira, Lucas Mendes (Universidade Federal de Minas Gerais (Brasil)) ;
Clark, Omar (Hospital Militar (Uruguai)) ;
Secin, Fernando (Centro de Educación Médica e Investigaciones Clinicas (Argentina)) ;
Rovegno, Agustín Roberto (Centro de Educación Médica e Investigaciones Clinicas (Argentina)) ;
Vilas, Ana (Hospital Pasteur. Departamento de Patologia (Uruguai)) ;
Barrios, Enrique (Facultad de Medicina. Departamento de Métodos Cuantitativos (Montevideo, Uruguai)) ;
Decia, Ricardo (Hospital Pasteur. Servicio de Urologia (Montevideo, Uruguai)) ;
Cardoso Guimarães, Gustavo (A.C. Camargo Cancer Center (Brasil)) ;
Glina, Sidney (Hospital Ipiranga (Brasil)) ;
Pal, Sumanta K. (City of Hope Medical Center (Duarte, Estats Units d'Amèrica)) ;
Rodríguez, Óscar (Fundació Puigvert) ;
Palou, Juan (Fundació Puigvert) ;
Spiess, Philippe (Lee Moffitt Cancer Center (Florida)) ;
Lara, Primo Nery (University of California Davis Comprehensive Cancer Center) ;
Marston Linehan, W. (National Cancer Institute (Bethesda, Estats Units d'Amèrica)) ;
Pastore, Antonio Luigi (Sapienza University of Rome. Department of Medico-Surgical Sciences and Biotechnologies) ;
Zequi, Stênio de Cássio (A.C. Camargo Cancer Center (Brasil))
PURPOSE To assess the effect of clinical and pathological variables on cancer-specific and overall survival (OS) in de novo metastatic patients from a collaborative of primarily Latin American countries. [...]
2021 - 10.1200/GO.20.00621
JCO global oncology, Vol. 7 (2021) , p. 671-685
|
|
|
7.
|
|
4 p, 270.8 KB |
Implementing a Checklist for Transurethral Resection of Bladder Tumor to Standardize Outcome Reporting : When High-quality Resection Could Influence Oncological Outcomes
/
Diana, Pietro (Fundació Puigvert) ;
Baboudjian, Michael (Fundació Puigvert) ;
Gallioli, Andrea (Fundació Puigvert) ;
Territo, Angelo (Fundació Puigvert) ;
Fontanet, Sofia (Fundació Puigvert) ;
Izquierdo, Paula (Fundació Puigvert) ;
Uleri, Alessandro (Fundació Puigvert) ;
Verri, Paolo (Fundació Puigvert) ;
Rodriguez-Faba, Óscar (Fundació Puigvert) ;
Gaya, Josep Maria (Fundació Puigvert) ;
Sanguedolce, Francesco (Fundació Puigvert) ;
Palou, Juan (Fundació Puigvert) ;
Breda, Alberto (Fundació Puigvert)
Several randomized controlled trials (RCTs) comparing en bloc resection of bladder tumor (ERBT) to conventional transurethral resection of bladder tumor (cTURBT) have reported controversial results. In particular, the 1-yr recurrence rate ranged from 5% to 40% for ERBT and from 11% to 31% for cTURBT. [...]
2022 - 10.1016/j.euros.2022.09.025
European Urology Open Science, Vol. 48 (december 2022) , p. 24-27
|
|
|
8.
|
|
22 p, 1.1 MB |
Non-muscle-invasive bladder cancer : An overview of potential new treatment options
/
Shore, Neal D. (Carolina Urologic Research Center) ;
Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Robert, Grégoire Y. (Department of Urology. CHU Bordeaux. University of Bordeaux) ;
Hutson, Thomas E. (Texas Oncology. Baylor Charles A. Sammons Cancer Center) ;
Cesari, Rossano (Pfizer Oncology) ;
Hariharan, Subramanian (Pfizer Oncology) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ;
Steinberg, Gary D. (Perlmutter Cancer Center. an NCI-designated Comprehensive Cancer Center Goldstein Bladder Cancer Program. NYU Langone Health. NYU Urology Associates. New York University) ;
Universitat Autònoma de Barcelona
Aim: This review article summarizes the current clinical practice guidelines around disease definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer (NMIBC). Recently completed and ongoing clinical trials of novel and investigational therapies in Bacillus Calmette-Guérin (BCG)-naïve, BCG-recurrent, and BCG-unresponsive patient populations are also described, e. [...]
2021 - 10.1016/j.urolonc.2021.05.015
Urologic Oncology: Seminars and Original Investigations, Vol. 39 Núm. 10 (october 2021) , p. 642-663
|
|
|
9.
|
|
7 p, 231.0 KB |
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer : a blinded prospective multicentric study
/
Gontero, P. (Department of Urology. Ospedale Molinette) ;
Montanari, E. (Department of Urology. Universita' Policlinico Milano) ;
Roupret, M. (Urology Department. GRC n°5. ONCOTYPE-URO. AP-HP. Hôpital Pitié-Salpêtrière. Sorbonne Université) ;
Longo, F. (Department of Urology. Universita' Policlinico Milano) ;
Stockley, Jacqueline (Arquer Diagnostics. R&D) ;
Kennedy, A. (Arquer Diagnostics. R&D) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
McCracken, S.R.C. (Sunderland Royal Hospital) ;
Dudderidge, T. (University Hospital Southampton) ;
Sieverink, C. (Radboud University Medical Centre. Department of Urology) ;
Vanié, F. (Urology Department. GRC n°5. ONCOTYPE-URO. AP-HP. Hôpital Pitié-Salpêtrière. Sorbonne Université) ;
Allasia, M. (Department of Urology. Ospedale Molinette) ;
Witjes, J.A. (Radboud University Medical Centre. Department of Urology) ;
Sylvester, R. (EAU Non-muscle-Invasive Guidelines Panel. EAU Guidelines Office) ;
Colombel, M. (Department of Urology. Hôpital Edouard Herriot) ;
Palou, Juan (Institut d'Investigació Biomèdica Sant Pau)
Objective: To compare directly the performance of the ADXBLADDER test with that of cytology in the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences. Background: ADXBLADDER is a urine test based on the detection of MCM5, a DNA licensing factor expressed in all cells capable of dividing. [...]
2021 - 10.1111/bju.15194
BJU International, Vol. 127 Núm. 2 (february 2021) , p. 198-204
|
|
|
10.
|
|
14 p, 2.5 MB |
Immunological status of bladder cancer patients based on urine leukocyte composition at radical cystectomy
/
Cantó, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Zamora, Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Mulet Gual, Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Garcia-cuerva, M.S. (Institut d'Investigació Biomèdica Sant Pau) ;
Palomino, Ana (Universitat Autònoma de Barcelona) ;
Anguera, Georgia (Institut d'Investigació Biomèdica Sant Pau) ;
Breda, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau)
Background: Bladder cancer (BC) is the ninth most common malignancy worldwide, with high rates of recurrence. The use of urine leukocyte composition at the time of radical cystectomy (RC) as a marker for the study of patients' immunological status and to predict the recurrence of muscle-invasive bladder cancer (MIBC) has received little attention. [...]
2021 - 10.3390/biomedicines9091125
Biomedicines, Vol. 9 Núm. 9 (2021) , p. 1125
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
